Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing
Next-generation sequencing (NGS) efforts have established catalogs of mutations relevant to cancer development. However, the clinical utility of this information remains largely unexplored. Here, we present the results of the first eight patients recruited into a clinical whole-genome sequencing (WG...
Huvudupphovsmän: | Schuh, A, Dreau, H, Knight, SJL, Ridout, K, Mizani, T, Vavoulis, D, Colling, R, Antoniou, P, Kvikstad, EM, Pentony, MM, Hamblin, A, Protheroe, A, Parton, M, Shah, KA, Zsolt, O, Athanasou, N, Hassan, B, Flanagan, AM, Ahmed, A, Winter, S, Harris, A, Tomlinson, I, Popitsch, N, Church, DN, Taylor, JC |
---|---|
Materialtyp: | Journal article |
Publicerad: |
Cold Spring Harbor Laboratory Press
2018
|
Liknande verk
Liknande verk
-
Utility of whole-genome sequencing in the clinical diagnostic of rare inherited anaemias
av: C Camps, et al.
Publicerad: (2018) -
The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
av: Schwarze, K, et al.
Publicerad: (2019) -
Whole-genome sequencing identifies homozygous BRCA2 deletion guiding treatment in dedifferentiated prostate cancer
av: Purshouse, K, et al.
Publicerad: (2017) -
Targeted next-generation sequencing of plasma DNA from cancer patients: factors influencing consistency with tumour DNA and prospective investigation of its utility for diagnosis
av: Kaisaki, P, et al.
Publicerad: (2016) -
ReliableGenome : annotation of genomic regions with high/low variant calling concordance
av: Popitsch, N, et al.
Publicerad: (2016)